avita medical

Avita Medical Limited is a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH). Avita was previously named Clinical Cell Culture Limited, which was established in 2002. The company develops and distributes highly innovative products in Regenerative and Respiratory Medicine.

The company's regenerative and tissue-engineered products provide revolutionary solutions utilising the patient's own skin and the regenerative capability of the human body to treat a wide range of wounds, scars and skin defects.

ReCell® is a stand-alone, rapid cell harvesting device that enables surgeons to treat skin defects using the patient's own cells. The surgeon can prepare a small quantity of cells within 30 minutes on site replacing the current technique of skin grafting or the requirement to send a biopsy to the laboratory for culture. ReCell® has been designed for use in a wide variety of burns, plastic, reconstructive and cosmetic procedures.ReCell® is gaining acceptance in a number of indications including Vitiligo, a common skin pigmentation disease.

ReCell® is patented, CE marked for the EU and TGA registered in Australia

Additionally, the companycommercialises innovative medical technologies for improved medication delivery and adherence in patients suffering from chronic respiratory diseases. The company manufactures and sells a range of spacers for the paediatric, adolescent and adult market and is the leading provider of spacers in Australia. Key respiratory products include the Funhaler® incentive asthma spacer designed specifically for the paediatric market. The Funhaler incorporate auditory and visual incentives to encourage children to comply with their medication plan and has been clinically demonstrated to improve compliance to prescribed medication and increase proper inhalation technique. The Funhaler® is patented, CE marked for the EU, FDA cleared for the US and TGA registered in Australia.

Breath-A-Tech is the leading spacer for adolescents and adults in Australia. The product is effective, compact, easy to use and competitively priced. The Breath-A-Tech hospital-grade spacer can also be autoclaved in the hospital or clinical setting.